Meridion, developers of advanced mass spectrometry instrumentation, has announced the availability of its patented dual-ionisation mass spectrometry platform, a next-generation analytical system. The portfolio is being represented by Becker Transactions, a patent brokerage firm, for acquisition or licensing.
The Meridion mass spectrometer addresses a limitation in conventional gas chromatography-mass spectrometry (GC/MS). The molecular ion is an essential signal for identifying an unknown compound, yet 30% of compounds lose this characteristic ion under the standard conditions required for electron-impact ionisation, reducing identification confidence. Whereas tandem GC/MS systems are optimised for known target compounds and are less suited for untargeted analysis.
The Meridion platform bridges this gap by generating two complementary mass spectra from every chromatographic peak within a single sample introduction: a positive-ion fragmentation spectrum compatible with existing reference library databases, and a negative-ion electron-capture spectrum that preserves the molecular ion. The result is doubled analytical information per compound without sacrificing compatibility with widely used identification tools.
Nicholas Wilton, founder of Meridion, said, “Meridion mass spectrometry’s central innovation isn’t just that we fundamentally improve GC/MS selectivity by generating two mass spectra per compound; it’s that we make this improvement without sacrificing one of GC/MS’s most powerful tools: reference library identification.”
The Meridion patent portfolio protects a unified architecture for simultaneous dual-polarity mass analysis, including:
- Dual ion source architecture: An instrument design combining a 70eV electron-impact source for positive-ion fragmentation with a trochoidal electron monochromator operating at variable energy for negative-ion electron capture- generating two independent datasets from every analyte.
- Multiple mass analyser configurations: Protected configurations include a polarity-switching quadrupole for alternating detection and a quadrupole electrostatic deflector system enabling simultaneous separation and detection of both ion polarities at the fastest available scan rates.
- Enhanced compound differentiation: The platform resolves the challenge of structurally similar compounds producing near-identical fragmentation patterns despite their different molecular weights, by readily distinguishing them based on their negative-ion signatures.
The Meridion platforms’ dual-data-stream approach is suitable for sectors requiring high-confidence compound identification in complex mixtures:
- Forensics and narcotics: Differentiation of structurally similar controlled substances that are indistinguishable by conventional fragmentation analysis alone. The platform also addresses the challenge of identifying novel psychoactive substances (NPS).
- Drug discovery: By tuning the secondary electron-capture source, novel chemicals and reaction byproducts can be identified by their intact molecular ions, accelerating the characterisation of unknown compounds in early-stage research.
- Untargeted metabolomics: The dual-spectrum approach provides richer datasets for discovery-phase analysis without sacrificing compatibility with existing spectral reference databases.
- Flavour, fragrance, and essential oils: Whole-product chemical profiling with improved characterisation of unknown compounds and greater certainty of identification.
Dean Becker, chairman of Becker Transactions, said, “Mass spectrometry is one of the most foundational analytical platforms in the life sciences, and compound identification confidence is its central value proposition. This portfolio gives acquirers a differentiated hardware IP position in a market where incremental improvements in selectivity translate directly to commercial advantage across forensics, pharma, and consumer products.”
There is a technical rigor in this discussion of dual ionisation mass spectrometry innovations, one that reflects a disciplined pursuit of clarity in chemical identification. The article highlights how integrating multiple ionisation techniques within a single GC MS framework allows scientists to capture a broader spectrum of compounds, overcoming the long standing limitation where a single ionisation method may fail to fully characterize complex mixtures. By enabling complementary detection modes, these patented approaches enhance both sensitivity and accuracy, particularly for compounds with differing polarity and volatility.